Pfizer Inc. (PFE) is around the top of the Drug Manufacturers - General industry according to InvestorsObserver. PFE received an overall rating of 46, which means that it scores higher than 46 percent of all stocks. Pfizer Inc. also achieved a score of 77 in the Drug Manufacturers - General industry, putting it above 77 percent of Drug Manufacturers - General stocks. Drug Manufacturers - General is ranked 131 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Pfizer Inc. Stock Today?
Pfizer Inc. (PFE) stock is higher by 0.3% while the S&P 500 is down -0.89% as of 10:20 AM on Tuesday, May 4. PFE has gained $0.12 from the previous closing price of $39.83 on volume of 13,511,916 shares. Over the past year the S&P 500 is higher by 46.17% while PFE has gained 12.09%. PFE earned $1.24 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 32.33.
Click Here to get the full Stock Score Report on Pfizer Inc. (PFE) Stock.
